Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis
Year: 2003
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2014574895
